These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26383058)

  • 21. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices.
    Hechtman L; Abikoff H; Klein RG; Greenfield B; Etcovitch J; Cousins L; Fleiss K; Weiss M; Pollack S
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):830-8. PubMed ID: 15213584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system.
    Frazier TW; Weiss M; Hodgkins P; Manos MJ; Landgraf JM; Gibbins C
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):355-64. PubMed ID: 20973706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):501-8. PubMed ID: 26262904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal treatments for childhood attention-deficit/hyperactivity disorder: interpreting outcomes in the context of study designs.
    Hoza B; Kaiser NM; Hurt E
    Clin Child Fam Psychol Rev; 2007 Dec; 10(4):318-34. PubMed ID: 17710545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
    Hechtman L; Abikoff H; Klein RG; Weiss G; Respitz C; Kouri J; Blum C; Greenfield B; Etcovitch J; Fleiss K; Pollack S
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):812-9. PubMed ID: 15213582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder.
    Silva R; Tilker HA; Cecil JT; Kowalik S; Khetani V; Faleck H; Patin J
    J Child Adolesc Psychopharmacol; 2004; 14(4):555-63. PubMed ID: 15662147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC; Schoemaker MM
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of patients with attention-deficit hyperactivity disorder by family practitioners.
    Eppright TD; Bradley S; Vogel SJ; Williamson HA
    Mo Med; 1998 Mar; 95(3):118-22. PubMed ID: 9529896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of parent training in combination with methylphenidate treatment on family relationships for children with attention deficit/hyperactivity disorder].
    Zhang Y; Kang CY; Zhao XR; Xuan X; Ding KJ; Liu RX; Wang YJ; Yang RX; Li XR; Wan S
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):185-9. PubMed ID: 24568915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial treatment issues in the MTA: a reply to Greene and Ablon.
    Hoza B
    J Clin Child Psychol; 2001 Mar; 30(1):126-30. PubMed ID: 11294071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
    Prada P; Nicastro R; Zimmermann J; Hasler R; Aubry JM; Perroud N
    Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attention deficit hyperactivity disorder].
    Cunill R; Castells X
    Med Clin (Barc); 2015 Apr; 144(8):370-5. PubMed ID: 24787685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany.
    Braun S; Russo L; Zeidler J; Linder R; Hodgkins P
    Clin Ther; 2013 May; 35(5):673-85. PubMed ID: 23587606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
    Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
    Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.